Functional analyses of thymic CD5+ B cells. Responsiveness to major histocompatibility complex class II-restricted T blasts but not to lipopolysaccharide or anti-IgM plus interleukin 4 by unknown
FUNCTIONAL ANALYSES OF THYMIC CD5+ B CELLS
Responsiveness to Major Histocompatibility Complex Class II-restricted
T Blasts but not to Lipopolysaccharide or Anti-IBM Plus Interleukin 4
BY MUNEO INABA,'l KAYO INABA,W YASUSHI ADACHI,* KEN-ICHI NANGO,'S
HAJIME OGATA,* SHIGERU MURAMATSU,W AND SUSUMU IKEHARA*T
From the *First Department ofPathology, $ The Liver Research Institute, and the §Department of
Ophthalmology, Kansai Medical University, Osaka, 570; and the WDepartment of Zoology,
Faculty of Science, Kyoto University, Kyoto, 606, Japan
In a previous report, we demonstrated that a small number ofB cells are present
in thethymus ofnormal mice, and that themajority ofthymic Bcells show thepheno-
type observed for Ly-1 + (CD5 +) B cells in other tissues (1) . Thus, the majority of
thymic B cells express surface CD5, IgM, B220 (CD45R), and Mac-1(CDllb), and
a lower amount ofMHC class II relative to peripheral B cells . The functions of the
CD5+ subset and the minorCD5- component in the thymus have not been deter-
mined, however, because of prior difficulties in isolating these B cells.
In this paper, we use a recent method for isolating thymic B cells to show that
theCD5 + subset has low responsiveness to B cell stimulants, such as LPS or IL-4,
but is inducedto grow and make antibody afteradirect interaction withMHC class
II-reactive T blasts .
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Mice.
￿
Female [BALB/c x DBA/2]F, and C3H/HeN mice were purchased from CLEA
Japan Inc . (Osaka, Japan) and maintained under specific pathogen-free conditions until use
at 6-8 wk of age .
Antibodies.
￿
mAbs to Thrl(F7D5) were purchased from Olac Ltd . (Bicester, UK), and
mAbs to CD4 (GK 1.5), CD8 (HO-2.2 and 3.155), and CD5 (C3PO) were from the Amer-
ican Type Culture Collection (Rockville, MD). Unconjugated or FITC-coupled rabbit
anti-mouse p chain F[ab']2 fragment were obtained from Cappel Laboratories (Malvern,
PA) . Biotinilated mAbs against CD5 (53.7 .3) and phycoerythrin (PE)-coupled avidin were
from Becton Dickinson & Co . (Mountain View, CA) .
CellPreparation.
￿
Thymic B cells were prepared as described (1). Briefly, low density thymus
cells floated with 65% Percoll were depleted ofT cells by treating with a mixture ofmAbs
to Thrl, CD4, andCD8 in the presence oflow toxic rabbit complement . After washing with
alkaline (pH ti7.4) RPMI 1640 medium to remove dead cells, the resulting population was
used as thymic B cells . B cells from spleens or lymph nodes were prepared by the same proce-
dure plus passage through a Sephadex G-10 column (Pharmacia Fine Chemicals, Uppsala,
Sweden) .
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MHC class II-restricted T blasts were isolated as the released blast population produced
from cell clusters of CD4' T cells and allogeneic spleen dendritic cells as described (2).
Isolation of CD5' andCD5- B Cellsfrom Thymic B Cells.
￿
Thymic B cells were double stained
with FITC-anti-,u and biotinated-anti-CD5 plus PE-avidine, and sorted into CD5' and CD5-
B cells using a FACStar. In some experiments, thymic and splenic B cells were treated with
anti-CD5 (C3PO) mAb plus rabbit complement to remove CD5' B cells.
Proliferative Assays.
￿
The proliferative assays were carried out as previously described (1).
AssaysforIblyclonal Ig Secretions.
￿
Cells (106/ml) were cultured with 10 kg/ml LPS for 1-5 d.
The secretion of IgM and IgG was measured by a reverse plaque assay usingclass-specific
rabbit anti-IgM and anti-IgG antibodies (ICN ImmunoBiochemicals, Lisle, IL).
Results
Low Responsiveness of Thymic B Cells to Standard B Cell Stimulation.
￿
The responses
of thymic B cells and splenic B cells to LPS or IL-4 were compared. As shown in
Fig. 1 A, the proliferative response of thymic B cells to LPS was significantly lower
than that of splenic B cells at all time points assessed (day 2-5). This was also the
case when the B cells were costimulated by anti-,u plus IL-4 (Fig. 1 B). Furthermore,
IgM and IgG production of splenic B cells in response to LPS was much higher
than those ofthymic B cells (Fig. 2). Similar results were obtained in thymic B cells
after passing through a Sephadex G-10 column (not shown). On the other hand,
the addition of a graded dose of thymic B cells to splenic B cells did not inhibit the
response to LPS (not shown), indicating that a low responsiveness of thymic B cells
is not due to suppressor cells.
To clarify why thymic B cells have a lower responsiveness to B cell stimulants,
we first examined the dose of LPS (10-50 hg/ml) or anti-14 (5-50 ltg/ml) required
for stimulation of thymic B cells and observed hyporesponsiveness to these at any
dose (not shown). Then we eliminated CD5' B cells by anti-CD5 mAb plus com-
plement. Proliferation and Ig secretion of thymic CD5- B cells were significantly
higher than those of bulk thymic B cell populations (not shown). We then fraction-
ated thymic B cells into CD5' and CD5 - B cells using a cell sorter after staining
with FITC-anti-h and biotinatedanti-CD5 plus PE-avidine. More than 70% of thymic
jA+ cells were CD5' (Fig. 3). After sorting, each subset was cultured for 4 d with
or without LPS. As shown in Table I, a very small number ofIgM-producing cells,
but not IgG-producing cells, were detected on day 0 (spontaneous Ig secretion) in
CD5' thymic B cells. After 4 d of stimulation with LPS, CD5' thymic B cells again
produced few IgM plaque-forming cells (PFCs) and no IgG PFCs. The CD5-
thymic B cellsdid have spontaneous IgM/IgG-producing cells, in contrast, and also
responded to LPS to produce many IgM and IgG PFCs.
FIGURE 1.
￿
Proliferative responses ofthymic Bcells. Thymic
(O) or splenic Bcells(0) at 105 cells/200141/well were cul-
turedwith 251+g/ml of LPS (A)or with rabbit anti-mouse
Ir chainantibody (10Wg/ml) plus rIL-4(10U/ml)(B)in 96-
well flat-bottomed culture plates. DNA synthesis was de-
termined by the incorporation of [3Hlthymidine (1140) for
the last 16 h of culture.m
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FIGURE 2.
￿
Polyclonal Ig secretion of thymic B cells. Thymic
(circles) or splenic(squares) B cells were cultured at 106 cells/ml/well
in 24-well plates in thepresence of 10 ug/ml LPS. The cells were
harvested on the days indicated in the figure. IgM- (open symbols)
and IgG- (closed symbols) producingcells were then determined by
a reversed plaque assay using a class-specific anti-Ig antibody.
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FIGURE 3.
￿
Double-stainingprofile ofthymic Bcells.
Thymic B cells were stained with FITC-anti-h
F[ab']2 antibody, and biotinylated-anti-CD5 mAb
plus PE-avidin. Dots, solid lines, and dashed lines
represent 1, 10, and 100 cells, respectively.
Responses of Thymic B Cells with Class II-restricted T Blasts.
￿
We next investigated
whether thymic B cells could respond better ifstimulated by the direct interaction
with T cells. Irradiated (25 Gy) alloreactive (lad-specific) T blasts (5 x 105 or 105
cells) were added to 2 x 106 thymic B cells, and polyclonal Ig-secreting cells were
assayed at 1-4 d. In fact, class II-restricted T blasts induced significant numbers
ofIgM, but not IgG, antibody-forming cellsfrom thymic B cells, theresponse reaching
a maximum at 3 d (Fig. 4A). B cell proliferation was also observed (Fig. 4 B). The
responsesofthymic B cells stimulatedby classII-restrictedTblasts were muchhigher
than those induced by LPS (Fig. 4). Both CD5+ and CD5- thymic B cells were
proliferatingin the presence ofclass II-restricted Tblasts whenassayedby flowcytom-
etry, i.e., analyses of cell size and CD5/sIgM staining (not shown).
To establish that CD5+ cells were responding to the T blasts, we did additional
experiments in which CD5+ cells were depleted after culture with T blasts. Elimi-
nation ofCD5+ cellsjust before the PFC assay caused a considerable reduction of
the numberofantibody-producing cells/culture, whereas treatment with anti-CD5
plus complement did not reduce the PFC in splenic B cell cultures (Table II). Also,
the few antibody-producing cellsthat developed in thymic B cells upon stimulation
with LPS were resistant to anti-CD5 mAb plus complement. We also found that324
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in contrast to splenic B cells, thymic B cells did not generate antibody-producing
cells in the presence of antigen (SRBC) plus allogeneic MLR culture supernatant.
These results indicate that direct interaction with T blasts is required for thymic
B cells to proliferate and differentiate to antibody-producing cells.
Discussion
It hasrecently been shown that asmall number of B cells arepresent in the thymus
of normal mice (1) and humans (3). From ourobservations, it seemsthat themajority
of these B cells are CD5' (70-80 17o of sIgM-bearing cells in the thymus), whereas
these cells are a minority in peripheral lymphoid organs. The function of CD5'
B cells present in the peritoneal cavity or spleen has been well characterized in
autoimmune-prone mice, such as NZB and [NZB x NZW]Ft mice, or in normal
BALB/c mice injected with LPS(4, 5). Here we have studied thefunction of thymic
Bcells in standard in vitro assays ofcell proliferation anddifferentiation. The results
showed that thymic B cells did not respond well to stimulation with LPS or anti-j.
plus rIL-4 (Figs. 1 and 2). The weak response that we observed could be ascribed
to CD5' B cells (Table II). This peculiar characteristic of CD5' may only be in
a population in the thymus, since CD5' B cells in peritonium have been reported
to respond to LPS stimulation (6).
A
Cells were assayed for polyclonal Ig secretionjust after sorting on a FAGS (see
Fig. 3) or after sorting plus culture with 10 Ftg/ml LPS for 4 d at 106 cells/ml
in 24-well plates.
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TABLE I
Polyclonal Ig Secretion of CD5' and CD5- Thymic B Cells
f--#-0
2 3 4 1 2 3 4 5
Days in Culture
B
Number of PFC/culture
2
I
1
i
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FIGURE 4.
￿
Stimulation ofthymic
B cells by direct interaction with
MHC class II-restricted T blasts.
Thymic B cells were cultured at 2 x
106 in 24-well plates with CD4' T
blasts of 5 x 105 (O), or 105 (O)
for polyclonal IgM secretion (A), or
at 2 x 105 in 96-well plates with
3 x 104 (0), 104 (p), or 3 x 103
(0) T blasts for proliferation (B).
Thymic B cells cultured in the ab-
sence ofT blasts (closedcircles) or in
the presence of LPS (open triangles,
10 and 25 ug/ml in A and B, re-
spectively) were controls. CD4' T
blasts were Iad specific and used
for experiments after irradiation at
25 Gy.
Cells
Day
IgM
0
IgG
Day
IgM
4
IgG
Bulk thymic B cells 415 70 2,750 650
CD5' thymic B cells 65 0 75 0
CD5- thymic B cells 640 55 4,450 860INABA ET AL.
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TABLE II
Polyclonal Ig Secretion of CD5+ Thymic B Cells after Interaction
with Ia-restricted CD4+ T Blasts
A number of IgM-secreting cells was assessed after 3-d culture of 2 x 106 B cells.
The B cells were treated with anti-CD5 (C3PO) mAb and complementjust be-
fore PFC assay. Irradiated lad-specific CD4' T blast (5 x 105), 10 ;+g/ml LPS,
or 20% allogeneic MLR supernatant plus 2 x 106 SRBC were used for stimu-
lation of the B cells. The viable cell recoveries after culture without stimulation
or with T blasts, LPS, or allo-MLR sup + SRBC were 3 x 105, 1 .26 x 106,
1 .24 x 106, and 7 .4 x 105 in thymic B cells, and 5.5 x 105, 1 .8 x 106, 3 .15 x
106, and 106 in splenic B cells, respectively.
CD5' B cells have been suggested to play an important role in maintaining IgM
serum levels in normal mice (7). However, significant spontaneous secretion ofIgM
in the thymic B cellswas not evident in our work (Fig. 2 and Table 1), a result that
is compatible with the work of Hayakawa et al. (4) using peritoneal CD5' B cells.
On the other hand, splenic or peritoneal CD5' B cells have been reported to pro-
duce antibodies against native DNA or Bromeline-treated autologous erythrocytes
when stimulated with LPS in vivo or even in vitro (5, 6, 8). This seems not to
be the case in thymic B cells, since purified CD5` thymic B cells cultured with LPS
did notshow anyIgM production(Table I). In addition, nosecretion ofanti-ssDNA
IgM antibodywasdetected (not shown). Possibly culture conditions such asdensity
or time ofculture explain the difference between thymic and splenic B cells. Alter-
natively, there is aqualitativedifference in the responsiveness ofsplenic and thymic
CD5' B cells to LPS.
Interestingly, however, thymic B cells proliferated upon direct interaction with
MHC class 11-restricted CD4+ T blasts (Fig. 4). This response seems largely due
to CD5' B cells (Table II). In ongoing experiments, we find that thymic B cells
stimulated with MHC class 11-restricted Tblasts are capableofproducing rheuma-
toid factor (not shown). It hasbeen shown that in patientswith rheumatoid arthritis,
CD5' B cells produce rheumatoid factor (9, 10).
The actual function of CD5' B cells in the thymus in situ is not clear. The
findings shown here suggest that the role of thymic CD5' B cells in situ may be
to interact directly with developing thymic lymphoblasts, but not to respond to ex-
ogenous antigens binding to surface Ig. This possibility is now under investigation.
Number of IgM-secreting
cells/culture
from treatment with:
B cells
from Stimulation for B cells None C' alone
Anti-CD5
+ C'
Thymus None 35 30 10
T blasts 2,690 2,490 750
LPS 670 645 590
allo-MLR sup + SRBC 30 20 10
Spleen None 85 105 95
T blasts 8,900 8,300 7,800
LPS 17,800 19,600 17,600
allo-MLR sup + SRBC 2,700 2,840 2,840326
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Summary
The function ofthymic B cells in several standard in vitro assays was investigated.
Thymic B cells, 7570 of which were CD5+ , showed a poor responsiveness to the
mitogens LPS or anti-a plus IL-4. Both proliferation and antibody formation were
much lower in thymic than splenic B cell cultures. However, CD5 - B cells purified
using a cell sorter responded well to B cell stimulants, whereas purified CD5 +
thymic B cells did not, indicating that CD5+ thymic B cells were unresponsive to
B cell growth factor or LPS. Thymic B cells could be activated polyclonally by direct
interaction with alloreactive T blasts, as manifested by DNA synthesis and antibody
formation. These findings indicate that CD5 + thymic B cells may not be stimulated
via sIg and IL-4, but require instead direct interaction with T blasts.
We thank Dr. Ralph M. Steinman for critical reading of this manuscript.
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